Kallikrein 14 Antikörper
-
- Target Alle Kallikrein 14 (KLK14) Antikörper anzeigen
- Kallikrein 14 (KLK14)
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Kallikrein 14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human KLK14
- Isotyp
- IgG
- Top Product
- Discover our top product KLK14 Primärantikörper
-
-
- Applikationshinweise
- WB 1:200-1:1000, IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Handhabung
- Avoid freeze / thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- Kallikrein 14 (KLK14)
- Andere Bezeichnung
- KLK14 (KLK14 Produkte)
- Synonyme
- GK14 antikoerper, KLK-L6 antikoerper, kallikrein related-peptidase 14 antikoerper, kallikrein related peptidase 14 antikoerper, Klk14 antikoerper, KLK14 antikoerper
- Hintergrund
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. An additional transcript variant has been described but its full length nature has not been determined.
- Molekulargewicht
- Calculated MW: 29 kDa
- NCBI Accession
- NP_071329
- Pathways
- Komplementsystem, Regulation of G-Protein Coupled Receptor Protein Signaling
-